Risk-benefit associated with azithromycin: A brief review

  • Pradhan A
  • Nahak A
  • Mohapatra G
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Introductions: Azithromycin is the most popular prescribed antimicrobial agent around the world. It comes under the class of macrolide antibiotics. Because of its higher efficacy, tolerance, and broad-spectrum activity, it is primarily used in upper and lower respiratory tract infections, some sexually transmitted infections, and major bacterial infections. Methods: Pieces of literature were reviewed to access the risk and benefits associated with azithromycin. Results: Generally, this is commercially available in solids, liquids, and ophthalmic formulations due to its minimal adverse events. It is also used in the case of COVID-19 drug therapy due to its pharmacological and therapeutic properties. Conclusions: The review of literature presented that it may increase the risk of cardiac death, hepatic injury, ototoxicity, hypersensitivity reactions.

Cite

CITATION STYLE

APA

Pradhan, A. K., Nahak, A., & Mohapatra, G. N. (2020). Risk-benefit associated with azithromycin: A brief review. Journal of Pharmacovigilance and Drug Research, 1(2), 1–5. https://doi.org/10.53411/jpadr.2020.1.2.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free